One of the most recently presented tools for performing in silico trials is the T1D patient decision simulator,20 which complements the UVA/Padova model of glucose, insulin, and glucagon dynamics in T1D patients21 with a model of T1D patients' behavior when making treatment decisions. Here, GCG is linked to type 1 diabetes mellitus.